About phio pharmaceuticals - PHIO
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
PHIO At a Glance
Phio Pharmaceuticals Corp.
11 Apex Drive
Marlborough, Massachusetts 01752
| Phone | 1-508-767-3861 | Revenue | 0.00 | |
| Industry | Biotechnology | Net Income | -8,698,000.00 | |
| Sector | Health Technology | Employees | 6 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
PHIO Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 0.605 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 1.60 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | N/A |
PHIO Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -1,449,666.667 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
PHIO Liquidity
| Current Ratio | 16.027 |
| Quick Ratio | 16.027 |
| Cash Ratio | 15.695 |
PHIO Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -63.897 |
| Return on Equity | -69.948 |
| Return on Total Capital | -43.173 |
| Return on Invested Capital | -69.948 |
PHIO Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |